208 related articles for article (PubMed ID: 22520821)
1. Immunohistochemical expression of E-cadherin and β-catenin in feline mammary tumours.
Zappulli V; De Cecco S; Trez D; Caliari D; Aresu L; Castagnaro M
J Comp Pathol; 2012; 147(2-3):161-70. PubMed ID: 22520821
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Rutteman GR; Gärtner Mde F
APMIS; 2007 Apr; 115(4):327-34. PubMed ID: 17504299
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of E-cadherin and β-catenin and high expression of basal cytokeratins in feline mammary carcinomas with regional metastasis.
Peñafiel-Verdu C; Buendia AJ; Navarro JA; Ramirez GA; Vilafranca M; Altimira J; Sanchez J
Vet Pathol; 2012 Nov; 49(6):979-87. PubMed ID: 22337774
[TBL] [Abstract][Full Text] [Related]
5. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
6. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.
Figueira AC; Gomes C; de Oliveira JT; Vilhena H; Carvalheira J; de Matos AJ; Pereira PD; Gärtner F
BMC Vet Res; 2014 Nov; 10():270. PubMed ID: 25424750
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.
Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C
Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables.
Matos AJ; Lopes C; Carvalheira J; Santos M; Rutteman GR; Gärtner F
J Comp Pathol; 2006; 134(2-3):182-9. PubMed ID: 16545841
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
[TBL] [Abstract][Full Text] [Related]
10. Nuclear translocation of β-catenin and decreased expression of epithelial cadherin in human papillomavirus-positive tonsillar cancer: an early event in human papillomavirus-related tumour progression?
Stenner M; Yosef B; Huebbers CU; Preuss SF; Dienes HP; Speel EJ; Odenthal M; Klussmann JP
Histopathology; 2011 Jun; 58(7):1117-26. PubMed ID: 21438909
[TBL] [Abstract][Full Text] [Related]
11. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
12. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
14. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
15. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model.
Sormunen RT; Leong AS; Vääräniemi JP; Fernando SS; Eskelinen SM
J Pathol; 1999 Mar; 187(4):416-23. PubMed ID: 10398100
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.
Xu L; Jiang Y; Zheng J; Xie G; Li J; Shi L; Fan S
Hum Pathol; 2013 Jul; 44(7):1357-64. PubMed ID: 23375645
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
18. Aberrant subcellular immunolocalization of NOTCH-1 activated intracellular domain in feline mammary tumours.
Ressel L; Else RW; Poli A; Argyle DJ
J Comp Pathol; 2014 May; 150(4):366-72. PubMed ID: 24529510
[TBL] [Abstract][Full Text] [Related]
19. [Abnormal expression of beta-catenin and E-cadherin in Her2-positive breast cancer and its implications].
Niu LG; He JJ; Wang K; Zhang W; Zhou C
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2237-40. PubMed ID: 19923077
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin and β-catenin expression in canine colorectal adenocarcinoma.
Aresu L; Pregel P; Zanetti R; Caliari D; Biolatti B; Castagnaro M
Res Vet Sci; 2010 Dec; 89(3):409-14. PubMed ID: 20457460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
